Dry Eye Society Melbourne: Lids, Lenses and The Latest in Dry Eye Management
Date: 1/09/2026 (AEST)
Venue: Chin Chin - 125 FLINDERS LANE, VIC, 3000
Provider: Dry Eye Society
Contact: Jason Holland, [E] jason.eyehealthcentre@hotmail.com, [P] 0412335422
Activity Outline
This exclusive Dry Eye Society member's event will provide two hours of Clinical CPD (1.5 hours of therapeutic CPD, 0.5hrs of interactive therapeutic CPD) and bring together leading experts to discuss practical, evidence-based approaches to managing dry eye disease. Dr Justin Friebel's presentation will explore the important relationship between eyelid abnormalities and dry eye disease.Leigh Plowman will present on Xiidra (lifitegrast). Jacinda Van and Michaela Rossi will present on contact lenses and their application in dry eye.
Learning Objectives
- Explore the important relationship between eyelid abnormalities and dry eye disease
- Explore the patient seletion and application of Xiidra (lifitegrast) for dry eye management
- Explore contact lenses and their application in dry eye.
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| Lid Abnormalities Associated with Dry Eye |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Xiidra: Where Does It Fit in Dry Eye Management? |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Contact Lenses for Dry Eye |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Expert Panel Q&A |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |